HomeAbout UsContact Us
Advanced Search
All CoursesCourses by SpecialtyRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
All Courses
Courses by Specialty
Featured Programs
 
Home : Advanced Search : Course view :






Course: Implementing Recommendations for HIV in the Primary Care Setting: an eTutorial™ Webcast 


 
Specialty: Infectious Diseases Format: Webcast 
Course #: 8701  Price: FREE  
Release date: 2010-02-24  Valid through: 2011-02-24 
Course viewing requirements (opens in a new window)
Instructions for Course Participation (opens in a new window)
Legal disclaimer (opens in a new window)


 
Target Audience:
This activity is designed to meet the educational needs of primary healthcare providers (MD, PA, NP, Pharmacists) who treat patients with HIV.

Agenda:

Introduction: 5 minutes
Presentations: 50 minutes
Post-Test & Evaluation: 10 minutes

Program Description:

Despite significant advances in the treatment of human immunodeficiency virus (HIV) infection, surveillance data have shown an increasing trend in new cases, with many cases diagnosed at an advanced stage. The Centers for Disease Control and Prevention (CDC) has issued recommendations for expanding screening and promoting earlier diagnosis of HIV infection. Primary care providers, who are on the front lines of patient care, are in the best position to improve screening practices and early HIV diagnosis. Both prevalence-based testing and risk-based testing require a thorough knowledge of epidemiologic trends and current statistical data, especially regarding subpopulations at increased risk for HIV.

In this program, we will discuss a number of issues that are important to primary care clinicians who manage patients at risk for, or who have recently become infected with HIV. The program will review epidemiologic and statistical prevalence data on HIV in the United States, the rationale for current efforts to expand screening, and methods to improve the primary care provider’s ability to diagnose this disease early in its course. We will also discuss the available types of HIV tests, some of the barriers to optimizing HIV testing, and strategies to overcome these barriers. In addition, we will review the latest evidence-based recommendations for managing HIV in treatment-naive patients. Finally, we will discuss how primary care providers can confidently integrate HIV management into their clinical practice.
Sponsor:
This activity is co-provided by Global Education Group and SCEPTER™.


Grantor
This activity is supported by an educational grant from Bristol-Myers Squibb.


Accreditation:
Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

There is no fee for this activity.
Credit Designation:
This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should only claim credit commensurate with the extent of their participation in the activity. For information about the nursing accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.
Faculty Listing:
Philip Keiser, MD
Professor of Medicine
The University of Texas Medical Branch
Galveston, Texas

Naiel N. Nassar, MD, FACP
Associate Professor of Clinical Medicine
Director, Infectious Diseases
Fellowship Program
University of California, San Francisco (UCSF), Fresno
Fresno, California


 
Subjects:
  • HIV
  • Infectious Disease
 
Objectives:
  • Identify high-risk behaviors that may impact the screening and early diagnosis of HIV in military veterans of the United States
  • Describe current guideline recommendations for diagnosis and initial treatment of HIV
  • Identify initial HIV treatment with regard to clinical practice of the military health care provider, consistent with current Veterans Affairs drug use guidelines
 
Financial Disclosure:
Policy on Disclosure

SCEPTER and Quintiles Medical Education adhere to the ACCME Essential Areas and Policies, including the Standards for Commercial Support, regarding industry support of CME. Disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, will be disclosed to learners.

Global Education Group (Global) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Off-Label Usage

The following faculty member(s) Philip Keiser, MD, and Naiel Nassar, MD, have indicated that their presentation(s) may include discussion of off-label, experimental, or investigational use of drugs or devices.

The faculty, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty:
Philip Keiser, MD, has served as a consultant for GlaxoSmithKline.

Naiel N. Nassar, MD, has no relevant financial relationships to disclose.

Moderator:
Vicki Huston has no relevant financial relationships to disclose.

Planners:
Jackie Dawson, Amanda Glazer, and Michael Perlmutter, MS, PharmD, have no significant financial relationships.

DISCLAIMER

The opinions expressed herein are those of the authors and do not necessarily represent the views of SCEPTER, Global Education Group, and Quintiles Medical Education. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Copyright

Copyright © 2009 SCEPTER, Global Education Group, and Quintiles Medical Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from SCEPTER, Global Education Group, and Quintiles Medical Education.
 
  • You are not currently logged in.
  • To view content articles and complete the post-test for this course, please login or register now

 



Copyright Notices  | Terms of Use  
Privacy Statement